Alaunos Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $124.0K | $354.0K | $1.4M | $1.9M | $2.9M | $319.0K | $1.1M | $1.7M |
| Accounts Receivable | $0 | $0 | $3.0K | $0 | $2.0K | $2.0K | $5.0K | $0 |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $666.0K | $970.0K | $2.0M | $2.7M | $3.7M | $1.1M | $2.8M | $3.6M |
| Property, Plant & Equipment | $74.0K | $82.0K | $91.0K | $97.0K | — | — | $0 | $0 |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.5M | $1.9M | $3.0M | $3.7M | $4.7M | $2.1M | $2.8M | $3.6M |
| Liabilities | ||||||||
| Accounts Payable | $732.0K | $400.0K | $613.0K | $843.0K | $809.0K | $831.0K | $516.0K | $458.0K |
| Total Current Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1.1M | $1.1M | $692.0K | $826.0K |
| Long-Term Debt | — | — | — | — | — | — | $0 | — |
| Total Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1.1M | $1.1M | $692.0K | $826.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-926.6M | $-925.6M | $-924.6M | $-923.7M | $-922.6M | $-921.5M | $-920.4M | $-919.7M |
| Total Stockholders' Equity | $652.0K | $1.3M | $2.2M | $2.8M | $3.7M | $1.1M | $2.1M | $2.7M |